Biopharm Business - BioPharm International

ADVERTISEMENT

Biopharm Business
Insight and analysis to business aspects of biopharmaceutical development. Mergers, acquisitions, legal activities.

Aggregation of Monoclonal Antibody Products: Formation and Removal

March 1, 2013

Aggregate formation is influenced by multiple aspects of the bioproduction process but can be mitigated by good process design and control.

Therapeutic Antibodies in Review

February 1, 2013

Innovative products and a range of indications drive the therapeutic antibody market.

Accelerating Change Marks 2012 for Life Sciences

January 1, 2013

A handful of therapeutics have performed extremely well in 2012, but as a whole, life-sciences are still down from 2010.

Biologics: What Does the Future Hold?

January 1, 2013

Neil Lewis, chief technology officer at Malvern Instruments, talks about the challenges associated with biologics.

Job Security in a Changing Biopharma Environment

December 1, 2012

Results from the 2012 employment survey.

Navigating Emerging Markets

December 1, 2012

An introduction to a new series on manufacturing within global markets.

Stability in Biopharmaceutical Storage

November 1, 2012

Patrick Jackson of Vindon Scientific offers key considerations for choosing an outsourced sample storage facility.

Recent Therapeutics IPOs Outshine Market, but Performance Mixed for Broader Life-Sciences Issues

October 1, 2012

A handful of therapeutics have performed extremely well in 2012, but as a whole, life-sciences are still down from 2010.

Streamlining Batch Record Review and Approval

August 1, 2012

A one-day sign off for batch records is considered a best practice in the industry.

ADVERTISEMENT

ADVERTISEMENT

Click here